Cargando…
Expert consensus on neoadjuvant immunotherapy for non-small cell lung cancer
Autores principales: | Liang, Wenhua, Cai, Kaican, Chen, Chun, Chen, Haiquan, Chen, Qixun, Fu, Junke, Hu, Jian, Jiang, Tao, Jiao, Wenjie, Li, Shuben, Liu, Changhong, Liu, Deruo, Liu, Wei, Liu, Yang, Ma, Haitao, Pan, Xiaojie, Qiao, Guibin, Tian, Hui, Wei, Li, Zhang, Yi, Zhao, Song, Zhao, Xiaojing, Zhou, Chengzhi, Zhu, Yuming, Zhong, Ran, Li, Feng, Rosell, Rafael, Provencio, Mariano, Massarelli, Erminia, Antonoff, Mara B., Hida, Toyoaki, de Perrot, Marc, Lin, Steven H., Di Maio, Massimo, Rossi, Antonio, De Ruysscher, Dirk, Ramirez, Robert A., Dempke, Wolfram C. M., Camidge, D. Ross, Guibert, Nicolas, Califano, Raffaele, Wang, Qi, Ren, Shengxiang, Zhou, Caicun, He, Jianxing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7815365/ https://www.ncbi.nlm.nih.gov/pubmed/33489828 http://dx.doi.org/10.21037/tlcr-2020-63 |
Ejemplares similares
-
A narrative review of primary research endpoints of neoadjuvant therapy for lung cancer: past, present and future
por: Ren, Sijia, et al.
Publicado: (2021) -
International expert consensus on immunotherapy for early-stage non-small cell lung cancer
por: Liang, Wenhua, et al.
Publicado: (2022) -
Overexpression of wildtype EGFR is tumorigenic and denotes a therapeutic target in non-small cell lung cancer
por: Xu, Naiqing, et al.
Publicado: (2015) -
Correction: Overexpression of wildtype EGFR is tumorigenic and denotes a therapeutic target in non-small cell lung cancer
por: Xu, Naiqing, et al.
Publicado: (2018) -
Application of indocyanine green injection guided by electromagnetic navigation bronchoscopy in localization of pulmonary nodules
por: Zhang, Jie, et al.
Publicado: (2021)